Miralax (Polyethylene Glycol 3350), Powder for Solution, Osmotic Laxative, 30 Once-Daily Doses, Net WT 17.9 OZ (510 g) bottle, Bayer Healthcare Pharmaceuticals, NDC 11523-7234-4.
Published August 17, 2022 · Recall initiated: June 29, 2022
Summary
FDA records drug Class II recall D-1319-2022, published August 17, 2022 and initiated June 29, 2022. Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office; Status: Terminated; Reported quantity: 67 bottles; Lot: Part# 11523723404. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: products were stored outside the drug label specifications.
What to do
Voluntary: Firm initiated · Letter
Get an email if MIRALAX has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MIRALAX
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Distributor
- Nationwide in the USA.
- UPC
- 0041100820716
- Lot
- Part# 11523723404
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADebrox, Carbamide Peroxide, Earwax Removal Aid, 0.5 FL OZ (15 mL) bottle per box), MedTech Products Inc., NDCAugust 17, 2022
- FDAGenTeal Tears, Lubricant Eye Ointment, Night-Time Ointment, Sterile, 3.5 gm (0.12 FL OZ) per box, Alcon, NDCAugust 17, 2022
- FDASystane Zaditor, ketotifen fumarate ophthalmic solution 0.035%, Antihistamine eye drops, Eye Itch Relief, upAugust 17, 2022
- FDAPataday, Once Daily Relief, Olopatadine hydrochloride ophthalmic solution 0.2%, Antihistamine, Eye AllergyAugust 17, 2022
- FDASystane Balance, Lubricant Eye Drops, Propylene Glycol 0.6% lubricant, Restorative Formula, Sterile, 10 mLAugust 17, 2022
- FDAA&D Original Ointment, Diaper Rash Ointment & Skin Protectant, 16 oz. Jar, Bayer Healthcare Pharmaceutica, NDCAugust 17, 2022
Questions about this recall
Was Miralax (Polyethylene Glycol 3350), Powder for Solution, Osmotic Laxative, 30 Once-Daily Doses, Net WT 17.9 OZ (510 g) bottle, Bayer Healthcare Pharmaceuticals, NDC 11523-7234-4. recalled?
Yes. FDA published recall D-1319-2022 on August 17, 2022. Reported hazard: CGMP Deviations: products were stored outside the drug label specifications.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MIRALAX. UPC: 0041100820716.